PNPLA2 and glaucoma: Our results suggest that a crucial neurodegeneration pathway in glaucoma may involve the effect of extracellular zinc on the activity of the neurotropic factor PEDF and consequently its receptor PEDF-R, which may thus represent relevant targets for neuroprotective therapy.